chartexchange

Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026

GlobeNewswire Inc. | Nov 3, 2026 8:00 AM EST

MONTREAL and CHARLOTTE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Milestone ®  Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will report its financial results for the third quarter ended September 30, 2026, and provide a business update before the market open. The announcement will be followed by a conference call and webcast for investors at 8:30 am ET.

Read original article